Searched for
ANTIFUNGAL INJECTION
Senores Pharma shares list at 53% premium over IPO priceSenores Pharmaceuticals’ shares debuted with over a 50% premium on Indian exchanges, reflecting a robust investor response to the IPO, whic...- Delhi police busts fake cancer drug racket: Here's how they sold Rs 100 drug for Rs 2 lakhThe Delhi Police have uncovered a massive fake drug operation in west Delhi’s Moti Nagar, involving the manufacturing and distribution of f...
- Aurobindo Pharma gets USFDA nod for generic antifungal injectionThe approval by the US Food & Drug Administration (USFDA) is for Posaconazole injection of 300 mg/16.7 mL (18 mg/mL), single-dose vial, Aur...
- Gufic Biosciences launches locally made botox injectionGufic said one of the important feature of ‘Zarbot’ is that it has been manufactured using purified HALL strain and proprietary technology ...
- Gufic Bio zooms 14%, hits 52-week high on drug approvalThe pharmaceutical firm received permission from Central Licensing Approving Authority, Central Drugs Standard Control Organisation (CDSCO)...
- How to check whether your vegetables are adulteratedThere are many ways by which your green leafy vegetables are adulterated. Now, you can use a simple method to find out whether your veggies...
- Zydus Cadila, Taiwan's TLC ink pact to market black fungus drug in IndiaThe Central Drugs Standard Control Organization has approved the new drug application (NDA) of TLC for Amphotericin B Liposome for Injectio...
- 111 black fungus cases found in Punjab so far: Health Minister Balbir Singh SidhuTwo injections are being provided to the states by the Union government in the treatment of black fungus. No one can procure these medicine...
- Black fungus cases near 400-mark in Haryana; Gurgaon sees max 147 casesWith rising number of black fungus or mucormycosis cases in the state on the rise, Health Minister Anil Vij chaired a meeting of senior off...
- MSN Labs launches black fungus drug Posaconazole in IndiaMSN Labs had earlier launched a Covid treatment portfolio of Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg, Oselow (Osel...
- Covid-19: Key drugs, steroids in short supply; input costs surgeTwo anti-virals — Remdesivir and Favipiravir — and Tocilizumab injections being used in the Covid-19 treatment have witnessed massive short...
- Five new companies get approval to boost fungus drug outputIt is understood that the health ministry’s expert committee which advises Drugs Controller General, recommended approval to Natco Pharma, ...
- Covid-19: Key anti-fungal drug scarcity new concernIn addition to the shortage, the treatment for this invasive fungal infection is a costly affair requiring Rs 15,000-Rs 20,000 per day for ...
- Advent to buy majority stake in Bharat SerumsUS-based private equity fund Advent International has signed a definitive agreement to acquire a majority stake in Bharat Serums and Vaccin...
- Coming soon: Novo Nordisk’s long-lasting insulin injectionNovo is betting big on Tresiba in the emerging markets after it failed to get an approval for the drug from the US Food and Drug Administra...
- Blood pressure drugs and antibiotics to be cheaper as government plans to notify price capsTop-selling blood pressure drugs and antibiotics could become a lot cheaper as the govt plans to notify price caps for 51 essential drugs
- Claris gets Russian nod for anti-infective drugsClaris raised Rs 300 crore in December through its maiden IPO. On Thursday, its stock dipped 2.48% to close at Rs 161.40.
- GlaxoSmithKline FY10 net profit up 10.37 pc to Rs 560.57 crGlaxoSmithKline Pharmaceuticals today said its consolidated net profit rose by 10.37 per cent to Rs 560.57 crore for the year ended Decembe...
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...
- Mankind Pharma eyes upto 10% equity saleUnlisted drug maker Mankind Pharma Ltd hopes this year to sell upto 10 per cent of its equity to domestic investors in a bid to raise funds...
Load More
